CCA
EW icon

Catalyst Capital Advisors’s Edwards Lifesciences EW Stock Holding History

Catalyst Capital Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-60
Closed -$49K – 459
2016
Q1 		$49K Hold
60
– – 0.01% 360
2015
Q4 		$32K Sell
60
-210
-78% -$5.45K ﹤0.01% 384
2015
Q3 		$101K Buy
+270
New +$6.52K 0.01% 325

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Catalyst Capital Advisors's EW Position: Q2 2026 in Review

Catalyst Capital Advisors opened a new position in Edwards Lifesciences (EW) in Q2 2026: 468 shares worth $42.3K. The stake represents ﹤0.01% of the portfolio and ranks #302 among its holdings. This is a return to the name: Catalyst Capital Advisors previously reported a position in EW as recently as Q4 2025.

Catalyst Capital Advisors first reported a position in EW in Q2 2013 and has held it in 19 quarters since. The position peaked at $3.05M in Q4 2017. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Catalyst Capital Advisors held 468 shares of Edwards Lifesciences worth $42.3K as of Q2 2026.
  • Edwards Lifesciences was a new Catalyst Capital Advisors position in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Catalyst Capital Advisors's portfolio in Q2 2026, its #302 holding.
  • Catalyst Capital Advisors first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 19 quarters since.
  • Catalyst Capital Advisors's Edwards Lifesciences position peaked at $3.05M in Q4 2017.
  • 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.